Subscribe to MDT Magazine News

Adeona to Raise $3.5 Million in Registered Direct Offering

April 7, 2011 7:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., April 7, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of 1,688,782 shares of its common stock at approximately $2.0725...


China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products

April 7, 2011 7:34 am | by Bio-Medicine.Org | Comments

HARBIN, China, April 7, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI ), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that the Company, jointly with...

Benzocaine Topical Products: Sprays, Gels and Liquids: Risk of Methemoglobinemia

April 7, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

FDA continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products.


TSMC disclose plans expansion in ?Mid-end? IC-packaging

April 7, 2011 5:37 am | by I-Micronews | Comments

During the TSMC 2011 Technology Symposium on Tuesday (April 5), Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) disclosed plans to expand its IC-packaging efforts reported EETimes.

Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing

April 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

ATLANTA, April 7, 2011 /- Vystar® Corporation (OTCBB:VYST), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw latex material that significantly reduces antigenic proteins and other non-rubbers found in natural rubber latex, has appointed Joanne...


Graymark Resupply Orders Reach Record Levels in Q1 2011, Up 107% Year-Over-Year

April 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

OKLAHOMA CITY, April 7, 2011 /- Graymark Healthcare Inc. (NASDAQ: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), realized a 107% year-over-year increase in patient resupply shipments in...


FDA Approves Horizant To Treat Restless Legs Syndrome

April 7, 2011 5:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 7, 2011 /PRNewswire-USNewswire/ -- On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). (Logo:...


Marinus Pharmaceuticals Issued Patent for Ganaxolone

April 7, 2011 5:35 am | by Bio-Medicine.Org | Comments

NEW HAVEN, Conn., April 7, 2011 /- Marinus Pharmaceuticals, Inc., the leader in development of neurosteroids for central nervous system disorders, today announced that the United States Patent and Trademark Office (USPTO) issued the company Patent Number 7,858,609 entitled, "Solid...


Shionogi Announces Commercial Availability of CUVPOSAâ„¢ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions

April 7, 2011 5:34 am | by Bio-Medicine.Org | Comments

FLORHAM PARK, N.J., April 7, 2011 /- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in...


NewCardio Study Shows my3KG Improves Diagnostic Accuracy in Diabetics With Acute Myocardial Infarction

April 7, 2011 5:33 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., April 7, 2011 /- PR Newswire – NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that the Company has been invited by the American Diabetes Association (ADA) to present the results of a key study showing that NewCardio's...


Cardinal Health to Release Third Quarter Results on April 28

April 7, 2011 4:37 am | by Bio-Medicine.Org | Comments

DUBLIN, Ohio, April 7, 2011 /- Cardinal Health plans to release third-quarter financial results for its fiscal 2011 on Thursday, April 28, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a webcast and conference call for April 28 at 8:30 a.m. EDT...

Data from FREEDOM-301 Study for LEVADEXâ„¢ Orally Inhaled Migraine Drug Published in 'Headache'

April 7, 2011 4:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., April 7, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced the publication of results from the Phase 3 FREEDOM-301 study of  LEVADEX™ orally inhaled migraine drug in the peer-reviewed journal 'Headache.' The manuscript, titled...


Reportlinker Adds Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011

April 7, 2011 4:35 am | by Bio-Medicine.Org | Comments

NEW YORK, April 7, 2011 /- announces that a new market research report is available in its catalogue: Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011...

Experts issue recommendations for evaluating and treating pituitary incidentalomas

April 7, 2011 4:33 am | by EurekAlert | Comments

(The Endocrine Society) Today, the Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism, a publication of the...


Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)

April 7, 2011 4:33 am | by Bio-Medicine.Org | Comments

NEW YORK, April 7, 2011 /- announces that a new market research report is available in its catalogue: European Markets for Interventional Cardiology Devices 2011 (15 Countries)...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.